Dual Regulation of Stat1 and Stat3 by the Tumor Suppressor Protein PML Contributes to IFNα-Mediated Inhibition of Angiogenesis.

Related Articles

Dual Regulation of Stat1 and Stat3 by the Tumor Suppressor Protein PML Contributes to IFNα-Mediated Inhibition of Angiogenesis.

J Biol Chem. 2017 Apr 21;:

Authors: Hsu KS, Zhao X, Cheng X, Guan D, Mahabeleshwar GH, Liu Y, Borden E, Jain MK, Kao HY

Abstract
IFNs are effective in inhibiting angiogenesis in preclinical models and in treating several angio-proliferative disorders. However, the detailed mechanisms of IFNα-mediated anti-angiogenesis are not completely understood. Stat1/2/3 and PML are IFNα downstream effectors and are pivotal regulators of angiogenesis. Here, we investigated PML's role in the regulation of Stat1/2/3 activity. In Pml knockout (KO) mice, ablation of Pml largely reduces IFNα angiostatic ability in Matrixgel plug assays. This suggested an essential role for PML in IFNα's anti-angiogenic function. We also demonstrated that PML shared a large cohort of regulatory genes with Stat1 and Stat3, indicating an important role of PML in regulating Stat1 and Stat3 activity. Using molecular tools and primary ECs, we demonstrated that PML positively regulates Stat1 and Stat2 isgylation, a ubiquitination-like protein modification. Accordingly, manipulation of the isgylation system by knocking down USP18 altered IFNα-PML axis-mediated inhibition of EC migration and network formation. Furthermore, PML promotes turnover of nuclear Stat3 and knockdown of PML mitigates the effect of LLL12, a selective Stat3 inhibitor, on IFNα-mediated anti-angiogenic activity. Taken together, we elucidated an unappreciated mechanism in which PML, an IFNα-inducible effector, possess potent angiostatic activity, doing so in part, by forming a positive feedforward loop with Stat1/2 and a negative feedback loop with Stat3. The interplay between PML, Stat1/Stat2 and Stat3 contributes to IFNα-mediated inhibition of angiogenesis and disruption of this network results in aberrant IFNα signaling and altered angiostatic activity.

PMID: 28432122 [PubMed - as supplied by publisher]

http://ift.tt/2pSTQXy